A genomic exploration identifies mechanisms that may explain adverse cardiovascular effects of COX-2 inhibitors-Reference-Cited by-同舟云学术

A genomic exploration identifies mechanisms that may explain adverse cardiovascular effects of COX-2 inhibitors

Published:2017-08-31 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Brænne Ingrid^ORCID,Willenborg Christina,Tragante Vinicius,Kessler Thorsten,Zeng Lingyao,Reiz Benedikt,Kleinecke Mariana,von Ameln Simon,Willer Cristen J.,Laakso Markku,Wild Philipp S.,Zeller Tanja,Wallentin Lars,Franks Paul W.,Salomaa Veikko,Dehghan Abbas,Meitinger Thomas,Samani Nilesh J.,Asselbergs Folkert W.^ORCID,Erdmann Jeanette^ORCID,Schunkert Heribert

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-10928-4.pdf

Reference53 articles.

1. Schmidt, M. et al. Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology. Eur Heart J 37, 1015–1023, doi: 10.1093/eurheartj/ehv505 (2016).

2. Antman, E. M. et al. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation 115, 1634–1642, doi: 10.1161/CIRCULATIONAHA.106.181424 (2007).

3. Cannon, C. P. & Cannon, P. J. Physiology. COX-2 inhibitors and cardiovascular risk. Science 336, 1386–1387, doi: 10.1126/science.1224398 (2012).

4. Nissen, S. E. et al. Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis. N Engl J Med 375, 2519–2529, doi: 10.1056/NEJMoa1611593 (2016).

5. Felson, D. T. Safety of Nonsteroidal Antiinflammatory Drugs. N Engl J Med 375, 2595–2596, doi: 10.1056/NEJMe1614257 (2016).

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polygenic Risk Score Associates With Atherosclerotic Plaque Characteristics at Autopsy;Arteriosclerosis, Thrombosis, and Vascular Biology;2024-01

2. ADAMTS-7 Modulates Atherosclerotic Plaque Formation by Degradation of TIMP-1;Circulation Research;2023-09-29

3. Polygenic Risk Score Associates with Atherosclerotic Plaque Characteristics at Autopsy;2023-07-09

4. The novel coronary artery disease risk factor ADAMTS-7 modulates atherosclerotic plaque formation by degradation of TIMP-1;2023-03-08

5. Pharmacogenomics in Stroke and Cardiovascular Disease: State of the Art;Stroke;2023-01